Difference detection is actual and extremely useful for evaluating a new medicine B against a specified disease by comparing to an old medicine A, which has been used to treat the disease for many years.
The breadth of the antibody response was evaluated against subtype A, B, C, and D variants of HIV-1.
Since travoprost did not meet EP-A criteria, the results were evaluated against EP-B criteria, which require reductions in bacterial counts of 1 and 3 logs at 24 hours and 7 days, respectively, with no increase at 28 days, and a 1 log reduction in fungal counts at 14 days, with no increase at 28 days.
1, 22 Prospective, comparative studies evaluating amphotericin B oral solution against other antifungals are limited.
When evaluated against EP-B criteria (Table 2), travoprost still did not satisfy EP requirements due to its limited effectiveness against Staphylococcus aureus at 24 hours (Table 3).
The present study was designed to evaluate whether Sal B protects against ATO-induced cardiac cell injury in vitro.
Responses against peptides of pool 4 could be only evaluated in the B group, where a similar pattern to that detected against pool 1 was found.
Fig. 4 a Numerically evaluated Q-factor and, b FoM plotted against the asymmetry parameter.
This study is part of a project evaluating vaccine effectiveness against Haemophilus influenzae type b which is financially supported by Sanofi Pasteur MSD and GlaxoSmithKline Biologicals (HK, BG, AM-B).
The cytotoxicity of the synthesized compounds was evaluated by a SRB (sulforhodamine B) assay against nine types of human cancer cell lines and inhibition against topoisomerase II (Topo II) of them was assessed by a decatenation assay.
A series of irreversible inhibitors of recombinant calpain has been synthesized and their rates of inactivation have been evaluated against calpain and cathepsin B, respectively.
